Exchange: NASDAQ·Updated 07:34 PM EDT
Upcoming Earnings: Q2 '26

Reports: Aug 12After Hours

Estimated EPS

$0.11

Estimated Rev

$20.2M

$OPRX Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.03 up 75.00% YoY • Reported revenue of $19.84M down -9.50% YoY • OptimizeRx updated its fiscal year 2026 guidance, now expecting revenue of $95M to $100M and adjusted EBITDA of $21M to $25M for the year.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '26
$0.11
--
--
N/A
Q1 '26
$0.00
$0.14
4100.42%
BEAT
Q4 '25
$0.22
$0.51
127.32%
BEAT
Q3 '25
$0.04
$0.20
442.01%
BEAT
Q2 '25
$0.02
$0.24
1333.43%
BEAT